The Role of Butyrate in Attenuating Pathobiont-Induced Hyperinflammation

키워드

참고문헌 (114)

1. Lappin E, "Gram-positive toxic shock syndromes", Lancet Infect Dis, 9, pp.281~290 (2009)
2. Hotchkiss RS, "Sepsis-induced immunosuppression : from cellular dysfunctions to immunotherapy", Nat Rev Immunol, 13, pp.862~874 (2013)
3. Hotchkiss RS, "Sepsis and septic shock", Nat Rev Dis Primers, 2, pp.16045~ (2016)
4. Wei Y, "Successful treatment with fecal microbiota transplantation in patients with multiple organ dysfunction syndrome and diarrhea following severe sepsis", Crit Care, 20, pp.332~ (2016)
5. Nagpal R, "Bacterial translocation from the gut to the distant organs : an overview", Ann Nutr Metab, 71(Suppl 1), pp.11~16 (2017)
6. Turner JR, "Intestinal mucosal barrier function in health and disease", Nat Rev Immunol, 9, pp.799~809 (2009)
7. Chen J, "Effects of intestinal microbial⁻elaborated butyrate on oncogenic signaling pathways", Nutrients, 11, pp.E1026~ (2019)
8. Jiminez JA, "Butyrate supplementation at high concentrations alters enteric bacterial communities and reduces intestinal inflammation in mice infected with Citrobacter rodentium", mSphere, 2, pp.e00243~ (2017)
9. Zhou Z, "Sodium butyrate ameliorates Corynebacterium pseudotuberculosis infection in RAW264. 7 macrophages and C57BL", 6 mice, 2019, pp.131, 144~149
10. Koren G, "Averting the foul taste of pediatric medicines improves adherence and can be lifesaving-Pheburane®(sodium phenylbutyrate)", Patient Prefer Adherence, 10, pp.2141~2144 (2016)
11. Jellbauer S, "Beneficial effects of sodium phenylbutyrate administration during infection with Salmonella enterica serovar Typhimurium", Infect Immun, 84, pp.2639~2652 (2016)
12. Sarker P, "Phenylbutyrate counteracts Shigella mediated downregulation of cathelicidin in rabbit lung and intestinal epithelia : a potential therapeutic strategy", PLoS One, 6, pp.e20637~ (2011)
13. Mily A, "Oral intake of phenylbutyrate with or without vitamin D3 upregulates the cathelicidin LL-37 in human macrophages : a dose finding study for treatment of tuberculosis", BMC Pulm Med, 13, pp.23~ (2013)
14. Mily A, "Significant effects of oral phenylbutyrate and vitamin D3 adjunctive therapy in pulmonary tuberculosis : a randomized controlled trial", PLoS One, 10, pp.e0138340~ (2015)
15. Yonezawa H, "Destructive effects of butyrate on the cell envelope of Helicobacter pylori", J Med Microbiol, 61, pp.582~589 (2012)
16. Martens EC, "Interactions of commensal and pathogenic microorganisms with the intestinal mucosal barrier", Nat Rev Microbiol, 16, pp.457~470 (2018)
17. Belzer C, "Microbes inside--from diversity to function : the case of Akkermansia", ISME J, 6, pp.1449~1458 (2012)
18. 정태환, "Butyrate modulates bacterial adherence on LS174T human colorectal cells by stimulating mucin secretion and MAPK signaling pathway", Nutrition Research and Practice, 9(4), pp.343~349 (2015), 한국영양학회[DOI]
19. Schilderink R, "The SCFA butyrate stimulates the epithelial production of retinoic acid via inhibition of epithelial HDAC", Am J Physiol Gastrointest Liver Physiol, 310, pp.G1138~ (2016)
20. Arbab Sikandar, "Effect of sodium butyrate on performance, immune status, microarchitecture of small intestinal mucosa and lymphoid organs in broiler chickens", Animal Bioscience, 30(5), pp.690~699 (2017), 아세아·태평양축산학회[DOI]
21. Onrust L, "Steering endogenous butyrate production in the intestinal tract of broilers as a tool to improve gut health", Front Vet Sci, 2, pp.75~ (2015)
22. Wrzosek L, "Bacteroides thetaiotaomicron and Faecalibacterium prausnitzii influence the production of mucus glycans and the development of goblet cells in the colonic epithelium of a gnotobiotic model rodent", BMC Biol, 11, pp.61~ (2013)
23. Katz JP, "The zinc-finger transcription factor Klf4 is required for terminal differentiation of goblet cells in the colon", Development, 129, pp.2619~2628 (2002)
24. Flandez M, "KLF4 regulation in intestinal epithelial cell maturation", Exp Cell Res, 314, pp.3712~3723 (2008)
25. Deng H, "Bacteroides fragilis prevents Clostridium difficile infection in a mouse model by restoring gut barrier and microbiome regulation", Front Microbiol, 9, pp.2976~ (2018)
26. Goldberg E, "The correlation between Clostridium-difficile infection and human gut concentrations of Bacteroidetes phylum and clostridial species", Eur J Clin Microbiol Infect Dis, 33, pp.377~383 (2014)
27. Pogribna M, "Effect of Aloe vera whole leaf extract on short chain fatty acids production by Bacteroides fragilis, Bifidobacterium infantis and Eubacterium limosum", Lett Appl Microbiol, 46, pp.575~580 (2008)
28. Zhao Y, "GPR43 mediates microbiota metabolite SCFA regulation of antimicrobial peptide expression in intestinal epithelial cells via activation of mTOR and STAT3", Mucosal Immunol, 11, pp.752~762 (2018)
29. Selsted ME, "Mammalian defensins in the antimicrobial immune response", Nat Immunol, 6, pp.551~557 (2005)
30. Hase K, "Cell differentiation is a key determinant of cathelicidin LL-37", human cationic antimicrobial protein 18 expression by human colon epithelium, 2002, pp.70, 953~963
31. Schauber J, "Expression of the cathelicidin LL-37 is modulated by short chain fatty acids in colonocytes : relevance of signalling pathways", Gut, 52, pp.735~741 (2003)
32. Schauber J, "Expression of the cathelicidin LL-37 is modulated by short chain fatty acids in colonocytes : relevance of signalling pathways", Gut, 52, pp.735~741 (2003)
33. Kang J, "Antimicrobial peptide LL-37 is bactericidal against Staphylococcus aureus biofilms", PLoS One, 14, pp.e0216676~ (2019)
34. Flemming A, "Butyrate boosts microbicidal macrophages", Nat Rev Immunol, 19, pp.135~ (2019)
35. Schulthess J, "The short chain fatty acid butyrate imprints an antimicrobial program in macrophages", Immunity, 50, pp.432~445 (2019)
36. Lobel L, "Butyrate makes macrophages"go nuclear"against bacterial pathogens", Immunity, 50, pp.275~278 (2019)
37. Singer-Englar T, "Obesity, diabetes, and the gut microbiome : an updated review", Expert Rev Gastroenterol Hepatol, 13, pp.3~15 (2019)
38. Byndloss MX, "Microbiota-activated PPAR-γ signaling inhibits dysbiotic Enterobacteriaceae expansion", Science, 357, pp.570~575 (2017)
39. Cani PD, "Gut cell metabolism shapes the microbiome", Science, 357, pp.548~549 (2017)
40. Rivera-Chávez F, "Oxygen as a driver of gut dysbiosis", Free Radic Biol Med, 105, pp.93~101 (2017)
41. Litvak Y, "Commensal Enterobacteriaceae protect against Salmonella colonization through oxygen competition", Cell Host Microbe, 25, pp.128~139 (2019)
42. Velazquez EM, "Endogenous Enterobacteriaceae underlie variation in susceptibility to Salmonella infection", Nat Microbiol, 4, pp.1057~1064 (2019)
43. Adediran J, "An Escherichia coli Nissle 1917 missense mutant colonizes the streptomycin-treated mouse intestine better than the wild type but is not a better probiotic", Infect Immun, 82, pp.670~682 (2014)
44. Chang PV, "The microbial metabolite butyrate regulates intestinal macrophage function via histone deacetylase inhibition", Proc Natl Acad Sci U S A, 111, pp.2247~2252 (2014)
45. Usami M, "Butyrate and trichostatin A attenuate nuclear factor kappaB activation and tumor necrosis factor alpha secretion and increase prostaglandin E2 secretion in human peripheral blood mononuclear cells", Nutr Res, 28, pp.321~328 (2008)
46. Kim HY, "Lipoproteins in Streptococcus gordonii are critical in the infection and inflammatory responses", Mol Immunol, 101, pp.574~584 (2018)
47. Bartual SG, "Three-dimensional structures of Lipoproteins from Streptococcus pneumoniae and Staphylococcus aureus", Int J Med Microbiol, 308, pp.692~704 (2018)
48. 박정우, "Short-chain Fatty Acids Inhibit Staphylococcal Lipoprotein-induced Nitric Oxide Production in Murine Macrophages", Immune Network, 19(2), pp.1~13 (2019), 대한면역학회
49. Vangan N, "mTORC1 mediates peptidoglycan induced inflammatory cytokines expression and NF-κB activation in macrophages", Microb Pathog, 99, pp.111~118 (2016)
50. Sahan-Firat S, "Protection by mTOR inhibition on zymosan-induced systemic inflammatory response and oxidative", nitrosative stress : contribution of mTOR, ERK1, pp.2, IKKβ[DOI]
51. Wang Z, "Inulin alleviates inflammation of alcoholic liver disease via SCFAs-inducing suppression of M1 and facilitation of M2 macrophages in mice", Int Immunopharmacol, 78, pp.106062~ (2020)
52. Wendy S. Garrett, "Immune recognition of microbial metabolites", Nature Reviews Immunology, 20(2), pp.91~92 (2020), Springer Science and Business Media LLC[DOI]
53. Cleophas MC, "Effects of oral butyrate supplementation on inflammatory potential of circulating peripheral blood mononuclear cells in healthy and obese males", Sci Rep, 9, pp.775~ (2019)
54. Hazem SH, "Comparison of lactate and β-hydroxybutyrate in the treatment of concanavalin-A induced hepatitis", Int Immunopharmacol, 61, pp.376~384 (2018)
55. Pan P, "Loss of FFAR2 promotes colon cancer by epigenetic dysregulation of inflammation suppressors", Int J Cancer, 143, pp.886~896 (2018)
56. Corrêa RO, "Bacterial short-chain fatty acid metabolites modulate the inflammatory response against infectious bacteria", Cell Microbiol, 19, pp.e12720~ (2017)
57. Gonçalves P, "A cross-talk between microbiota-derived short-chain fatty acids and the host mucosal immune system regulates intestinal homeostasis and inflammatory bowel disease", Inflamm Bowel Dis, 24, pp.558~572 (2018)
58. Simeoli R, "An orally administered butyrate-releasing derivative reduces neutrophil recruitment and inflammation in dextran sulphate sodium-induced murine colitis", Br J Pharmacol, 174, pp.1484~1496 (2017)
59. Vinolo MA, "Suppressive effect of short-chain fatty acids on production of proinflammatory mediators by neutrophils", J Nutr Biochem, 22, pp.849~855 (2011)
60. Kim J, "Cutting edge : depletion of Foxp3+ cells leads to induction of autoimmunity by specific ablation of regulatory T cells in genetically targeted mice", J Immunol, 183, pp.7631~7634 (2009)
61. Smith PM, "The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis", Science, 341, pp.569~573 (2013)
62. Arpaia N, "Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation", Nature, 504, pp.451~455 (2013)
63. Furusawa Y, "Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells", Nature, 504, pp.446~450 (2013)
64. Singh N, "Activation of Gpr109a, receptor for niacin and the commensal metabolite butyrate, suppresses colonic inflammation and carcinogenesis", Immunity, 40, pp.128~139 (2014)
65. Honore PM, "Cytokine removal in human septic shock : where are we and where are we going", Ann Intensive Care, 9, pp.56~ (2019)
66. Chen J, "Inflammation-modulating effect of butyrate in the prevention of colon cancer by dietary fiber", Clin Colorectal Cancer, 17, pp.e541~ (2018)
67. Yang XO, "T helper 17 lineage differentiation is programmed by orphan nuclear receptors ROR alpha and ROR gamma", Immunity, 28, pp.29~39 (2008)
68. Korn T, "IL-17 and Th17 cells", Annu Rev Immunol, 27, pp.485~517 (2009)
69. Chaudhry A, "CD4+ regulatory T cells control TH17 responses in a Stat3-dependent manner", Science, 326, pp.986~991 (2009)
70. Das S, "Yin and yang of interleukin-17 in host immunity to infection", F1000 Res, 6, pp.741~ (2017)
71. Asseman C, "An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation", J Exp Med, 190, pp.995~1004 (1999)
72. Fiorentino DF, "IL-10 inhibits cytokine production by activated macrophages", J Immunol, 147, pp.3815~3822 (1991)
73. Okeke EB, "The pivotal role of regulatory T cells in the regulation of innate immune cells", Front Immunol, 10, pp.680~ (2019)
74. Tiemessen MM, "CD4+CD25+Foxp3+ regulatory T cells induce alternative activation of human monocytes", macrophages, 2007, pp.104, 19446~19451
75. Zhang H, "Butyrate suppresses murine mast cell proliferation and cytokine production through inhibiting histone deacetylase", J Nutr Biochem, 27, pp.299~306 (2016)
76. Liu L, "Butyrate interferes with the differentiation and function of human monocyte-derived dendritic cells", Cell Immunol, 277, pp.66~73 (2012)
77. Millard AL, "Butyrate affects differentiation, maturation and function of human monocyte-derived dendritic cells and macrophages", Clin Exp Immunol, 130, pp.245~255 (2002)
78. Zimmerman MA, "Butyrate suppresses colonic inflammation through HDAC1-dependent Fas upregulation and Fas-mediated apoptosis of T cells", Am J Physiol Gastrointest Liver Physiol, 302, pp.G1405~ (2012)
79. Fu X, "Nondigestible carbohydrates, butyrate, and butyrate-producing bacteria", Crit Rev Food Sci Nutr, 59, pp.S130~ (2019)
80. Vital M, "Revealing the bacterial butyrate synthesis pathways by analyzing(meta)genomic data", MBio, 5, pp.e00889~ (2014)
81. Louis P, "Restricted distribution of the butyrate kinase pathway among butyrate-producing bacteria from the human colon", J Bacteriol, 186, pp.2099~2106 (2004)
82. Ganesan K, "Causal relationship between diet-induced gut microbiota changes and diabetes : a novel strategy to transplant Faecalibacterium prausnitzii in preventing diabetes", Int J Mol Sci, 19, pp.E3720~ (2018)
83. Roychowdhury S, "Faecalibacterium prausnitzii and a prebiotic protect intestinal health in a mouse model of antibiotic and Clostridium difficile exposure", JPEN J Parenter Enteral Nutr, 42, pp.1156~1167 (2018)
84. Deng H, "Bacteroides fragilis prevents Clostridium difficile infection in a mouse model by restoring gut barrier and microbiome regulation", Front Microbiol, 9, pp.2976~ (2018)
85. Eeckhaut V, "Butyricicoccus pullicaecorum in inflammatory bowel disease", Gut, 62, pp.1745~1752 (2013)
86. Zhang J, "Beneficial effect of butyrate-producing Lachnospiraceae on stress-induced visceral hypersensitivity in rats", J Gastroenterol Hepatol, 34, pp.1368~1376 (2019)
87. Maier E, "Live Faecalibacterium prausnitzii induces greater TLR2 and TLR2", 6 activation than the dead bacterium in an apical anaerobic co-culture system, 2018, pp.20, e12805~
88. Rivière A, "Bifidobacteria and butyrate-producing colon bacteria : importance and strategies for their stimulation in the human gut", Front Microbiol, 7, pp.979~ (2016)
89. Rios-Covian D, "Enhanced butyrate formation by cross-feeding between Faecalibacterium prausnitzii and Bifidobacterium adolescentis", FEMS Microbiol Lett, 362, pp.fnv176~ (2015)
90. Moens F, "Bifidobacterial inulin-type fructan degradation capacity determines cross-feeding interactions between bifidobacteria and Faecalibacterium prausnitzii", Int J Food Microbiol, 231, pp.76~85 (2016)
91. Laval L, "Lactobacillus rhamnosus CNCM I-3690 and the commensal bacterium Faecalibacterium prausnitzii A2-165 exhibit similar protective effects to induced barrier hyper-permeability in mice", Gut Microbes, 6, pp.1~9 (2015)
92. Carlson JL, "Health effects and sources of prebiotic dietary fiber", Curr Dev Nutr, 2, pp.nzy005~ (2018)
93. Holscher HD, "Dietary fiber and prebiotics and the gastrointestinal microbiota", Gut Microbes, 8, pp.172~184 (2017)
94. Lordan C, "Potential for enriching next-generation health-promoting gut bacteria through prebiotics and other dietary components", Gut Microbes, 11, pp.1~20 (2020)
95. La Rosa SL, "Wood-derived dietary fibers promote beneficial human gut microbiota", mSphere, 4, pp.e00554~ (2019)
96. Tochio T, "1-kestose, the smallest Fructooligosaccharide component, which efficiently stimulates Faecalibacterium prausnitzii as well as bifidobacteria in humans", Foods, 7, pp.E140~ (2018)
97. Poeker SA, "Understanding the prebiotic potential of different dietary fibers using an in vitro continuous adult fermentation model(PolyFermS)", Sci Rep, 8, pp.4318~ (2018)
98. Zhang Y, "Caecal infusion of the short-chain fatty acid propionate affects the microbiota and expression of inflammatory cytokines in the colon in a fistula pig model", Microb Biotechnol, 11, pp.859~868 (2018)
99. Tedelind S, "Anti-inflammatory properties of the short-chain fatty acids acetate and propionate : a study with relevance to inflammatory bowel disease", World J Gastroenterol, 13, pp.2826~2832 (2007)
100. Pool-Zobel BL, "Overview of experimental data on reduction of colorectal cancer risk by inulin-type fructans", J Nutr, 137, pp.2580~ (2007)
101. Cherbut C, "Inulin and oligofructose in the dietary fibre concept", Br J Nutr, 87(Suppl 2), pp.S159~S162 (2002)
102. Kilua A, "Purple sweet potato polyphenols differentially influence the microbial composition depending on the fermentability of dietary fiber in a mixed culture of swine fecal bacteria", Nutrients, 11, pp.E1495~ (2019)
103. Ramirez-Farias C, "Effect of inulin on the human gut microbiota : stimulation of Bifidobacterium adolescentis and Faecalibacterium prausnitzii", Br J Nutr, 101, pp.541~550 (2009)
104. Hryckowian AJ, "Microbiota-accessible carbohydrates suppress Clostridium difficile infection in a murine model", Nat Microbiol, 3, pp.662~669 (2018)
105. Fachi JL, "Butyrate protects mice from Clostridium difficile-induced colitis through an HIF-1-dependent mechanism", Cell Reports, 27, pp.750~761 (2019)
106. Chung WSF, "Prebiotic potential of pectin and pectic oligosaccharides to promote anti-inflammatory commensal bacteria in the human colon", FEMS Microbiol Ecol (2017)
107. Chen Y, "Butyrate from pectin fermentation inhibits intestinal cholesterol absorption and attenuates atherosclerosis in apolipoprotein E-deficient mice", J Nutr Biochem, 56, pp.175~182 (2018)
108. Ferreira-Lazarte A, "Behaviour of citrus pectin during its gastrointestinal digestion and fermentation in a dynamic simulator(simgi®)", Carbohydr Polym, 207, pp.382~390 (2019)
109. Bianchi F, "In vitro modulation of human gut microbiota composition and metabolites by Bifidobacterium longum BB-46 and a citric pectin", Food Res Int, 120, pp.595~602 (2019)
110. Karetkin BA, "A quantitative model of Bacillus cereus ATCC 9634 growth inhibition by bifidobacteria for synbiotic effect evaluation", World J Microbiol Biotechnol, 35, pp.89~ (2019)
111. Moens F, "Inulin-type fructan degradation capacity of Clostridium cluster IV and XIVa butyrate-producing colon bacteria and their associated metabolic outcomes", Benef Microbes, 8, pp.473~490 (2017)
112. Remely M, "Increased gut microbiota diversity and abundance of Faecalibacterium prausnitzii and Akkermansia after fasting : a pilot study", Wien Klin Wochenschr, 127, pp.394~398 (2015)
113. Rangan P, "Fasting-mimicking diet modulates microbiota and promotes intestinal regeneration to reduce inflammatory bowel disease pathology", Cell Reports, 26, pp.2704~2719 (2019)
114. Zhou ZL, "Neuroprotection of fasting mimicking diet on MPTP-induced Parkinson's disease mice via gut microbiota and metabolites", Neurotherapeutics, 16, pp.741~760 (2019)

관련 논문AI추천